![Kelli Luginbuhl](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Kelli Luginbuhl
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Isolere Bio, Inc.
![]() Isolere Bio, Inc. Pharmaceuticals: MajorHealth Technology Part of Donaldson Co., Inc., Isolere Bio, Inc. is an early-stage biotechnology company that develops novel and proprietary reagents. The company is based in Durham, NC. The company was founded in 2017 by Kelli Luginbuhl, Joseph McMahon, Ashutosh Chilkoti. Kelli Luginbuhl has been the CEO since 2017. Isolere Bio was acquired by Donaldson Co., Inc. on February 21, 2023 for $62.50 million. | Algemeen Directeur | 01-01-2017 | - |
Oprichter | 01-01-2017 | - |
Loopbaan van Kelli Luginbuhl
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Chief Executive Officer | 1 |
Founder | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Isolere Bio, Inc.
![]() Isolere Bio, Inc. Pharmaceuticals: MajorHealth Technology Part of Donaldson Co., Inc., Isolere Bio, Inc. is an early-stage biotechnology company that develops novel and proprietary reagents. The company is based in Durham, NC. The company was founded in 2017 by Kelli Luginbuhl, Joseph McMahon, Ashutosh Chilkoti. Kelli Luginbuhl has been the CEO since 2017. Isolere Bio was acquired by Donaldson Co., Inc. on February 21, 2023 for $62.50 million. | Health Technology |
- Beurs
- Insiders
- Kelli Luginbuhl
- Ervaring